The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted
homeostatic regulator, which influences a wide-variety of physiological processes all over …

The year 2020 became the year of the outbreak of coronavirus, SARS-CoV-2, which
escalated into a worldwide pandemic and continued into 2021. One of the unique symptoms …

Endocannabinoids (eCBs) are lipid-based retrograde messengers with a relatively short half-
life that are produced endogenously and, upon binding to the primary cannabinoid receptors …

The endocannabinoid system is represented by a group of neuromodulatory lipids and their
receptors that are involved in a variety of physiological and pathological conditions. The …

Neuropathic pain in humans arises as a consequence of injury or disease of somatosensory
nervous system at peripheral or central level. Peripheral neuropathic pain is more common …

Cannabinoids might be a suitable treatment for RA, but it is important to target the right
receptors in the right place. For clinical studies, we propose a combination of a CB 2 agonist …

This paper is the thirty-ninth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2016 …

Autism spectrum disorder (ASD) is a group of disabilities with impairments in physical,
verbal, and behavior areas. Regardless the growing frequency of autism, no medicine has …

Abstract CB2 cannabinoid receptors (CB2) are a promising therapeutic target that lacks
unwanted side effects of CB1 activation. However, the cell types expressing CB2 that …

Cannabis has been used for centuries to treat pain. The antinociceptive activity of
tetrahydrocannabinol (THC) or cannabidiol (CBD) has been widely studied. However, the …